FIC Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$557K Sell
8,740
-25
-0.3% -$1.46K 0.21% 86
2017
Q2
$488K Hold
8,765
0.2% 88
2017
Q1
$477K Hold
8,765
0.21% 85
2016
Q4
$512K Sell
8,765
-6,200
-41% -$339K 0.26% 82
2016
Q3
$807K Sell
14,965
-55
-0.4% -$3.53K 0.36% 70
2016
Q2
$1.1M Buy
15,020
+50
+0.3% +$3.53K 0.52% 57
2016
Q1
$956K Sell
14,970
-300
-2% -$18.9K 0.46% 59
2015
Q4
$1.05M Sell
15,270
-100
-0.7% -$6.61K 0.47% 62
2015
Q3
$910K Buy
15,370
+1,150
+8% +$73K 0.43% 63
2015
Q2
$946K Sell
14,220
-200
-1% -$13.2K 0.38% 69
2015
Q1
$930K Hold
14,420
0.35% 77
2014
Q4
$851K Hold
14,420
0.33% 86
2014
Q3
$738K Buy
14,420
+200
+1% +$9.99K 0.3% 94
2014
Q2
$690K Sell
14,220
-200
-1% -$9.86K 0.27% 102
2014
Q1
$749K Hold
14,420
0.31% 97
2013
Q4
$766K Sell
14,420
-150
-1% -$7.64K 0.34% 100
2013
Q3
$674K Buy
14,570
+6,850
+89% +$301K 0.34% 98
2013
Q2
$345K Buy
+7,720
New +$335K 0.22% 109

Other funds holding BMY

FIC Capital's BMY Position: Q3 2017 in Review

FIC Capital reduced its Bristol-Myers Squibb (BMY) stake by 0.29% in Q3 2017, selling an estimated $1.46K and leaving 8,740 shares worth $557K. The position accounts for 0.21% of the portfolio, ranked #86.

FIC Capital first reported a position in BMY in Q2 2013 and has held it in 18 quarters since. The position peaked at $1.1M in Q2 2016. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

  • FIC Capital held 8,740 shares of Bristol-Myers Squibb worth $557K as of Q3 2017.
  • FIC Capital sold 25 Bristol-Myers Squibb shares in Q3 2017, an estimated $1.46K.
  • Bristol-Myers Squibb made up 0.21% of FIC Capital's portfolio in Q3 2017, its #86 holding.
  • FIC Capital first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 18 quarters since.
  • FIC Capital's Bristol-Myers Squibb position peaked at $1.1M in Q2 2016.
  • 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on FIC Capital's 13F filing for Q3 2017, filed 14 Nov 2017.